01
True or false
1 point
True or false: In an acute cardiovascular assessment, evaluate the patient’s condition and perfusion before focusing on the monitor tracing.
Free Practice Quiz Question List
7 Cardiovascular Clinical Practice Cases Online Quiz Questions
Use this free practice quiz with 20 questions to review 7 Cardiovascular Clinical Practice Cases, test your knowledge, and prepare for your next test or exam.
20 questions
02
Choose one
1 point
A stable, alert patient has sudden palpitations and a regular narrow-complex rhythm at 190/min. Which intervention should be tried first, alongside monitoring and assessment?
- A
Immediate unsynchronized defibrillation
- B
A vagal maneuver
- C
Immediate synchronized cardioversion
- D
Routine rate-control medication before reassessment
03
Written response
1 point
A patient has sudden palpitations and a regular narrow-complex rhythm. What rhythm category is identified as a possible interpretation?
04
Fill in the blank
1 point
Adenosine is intended for rhythms; it is not a general treatment for irregular tachycardia.
05
Choose one
1 point
A patient with an irregularly irregular rhythm at 170/min is hypotensive, confused, and cool and clammy. What is the immediate priority for this unstable tachyarrhythmia with a pulse?
- A
Try routine rate-control medication before deciding on cardioversion
- B
Wait for anticoagulation assessment before intervening
- C
Prepare for immediate synchronized cardioversion
- D
Use unsynchronized defibrillation as the initial treatment for this pulsed rhythm
06
True or false
1 point
True or false: Every patient with suspected acute myocardial infarction should routinely receive oxygen, regardless of oxygenation.
- A
True
- B
False
07
Written response
1 point
Which medication class is included in guideline-directed therapy for heart failure with reduced ejection fraction, including for some patients without diabetes?
08
Choose all
1 point
Once a patient with HFrEF is stabilized, select all four medication classes included in guideline-directed disease-modifying therapy.
- A
An angiotensin receptor–neprilysin inhibitor, or an ACE inhibitor/ARB when appropriate
- B
A loop diuretic as the only disease-modifying therapy
- C
An evidence-based beta-blocker
- D
A mineralocorticoid receptor antagonist
- E
Aspirin plus a P2Y12 inhibitor
- F
An SGLT2 inhibitor
09
Choose one
1 point
A patient has chest pressure, sweating, nausea, and ST-segment elevation in contiguous ECG leads. What is the priority system-level action?
- A
Wait to see whether the chest pressure resolves before contacting the emergency team
- B
Activate emergency ACS and reperfusion pathways immediately
- C
Use nitroglycerin response to determine whether myocardial infarction is present
- D
Delay escalation until all medication choices have been finalized
10
Choose one
1 point
Before considering nitroglycerin for a patient with suspected acute myocardial infarction, which assessment is essential?
- A
Give it without checking blood pressure if chest pain is present
- B
Use improvement after a dose to rule out myocardial infarction
- C
Give it before assessing for contraindications because it replaces reperfusion
- D
Assess blood pressure and contraindications before administration
11
Fill in the blank
1 point
For persistent symptomatic bradycardia with cardiopulmonary compromise, if atropine is ineffective, one escalation option is .
12
Choose all
1 point
A patient with known heart failure has worsening breathlessness, crackles, edema, and low oxygen saturation. Select all appropriate immediate actions or precautions.
- A
Sit the patient upright
- B
Give oxygen routinely regardless of oxygenation
- C
Give oxygen when hypoxemia is present
- D
Reflexively give a fluid bolus despite pulmonary congestion
- E
Avoid reflexively giving a fluid bolus when pulmonary congestion is present
- F
Start or increase a beta-blocker as an acute response to severe decompensation
13
Choose one
1 point
When reviewing disease-modifying medications for a patient with HFrEF, which combination should be avoided?
- A
Combine an ACE inhibitor with an ARNI to strengthen disease-modifying therapy
- B
Use both medications together if potassium is normal
- C
Avoid combining an ACE inhibitor with an ARNI
- D
Ignore kidney function if the patient is taking an ARNI
14
Open ended
1 point
Explain why a beta-blocker may be part of long-term HFrEF therapy but is generally not started or titrated as an acute response to shock or severe decompensation.
15
True or false
1 point
True or false: If nitroglycerin relieves a patient's chest discomfort, myocardial infarction is ruled out.
- A
True
- B
False
16
Choose one
1 point
A patient with HFrEF does not have diabetes. Which statement about SGLT2 inhibitors is supported by the treatment guidance?
- A
Only for patients with diabetes
- B
For HFrEF, including in patients without diabetes
- C
Only during acute pulmonary edema
- D
As a substitute for all other HFrEF therapies
17
Written response
1 point
Which medication class should not be combined with an angiotensin receptor–neprilysin inhibitor (ARNI) in HFrEF therapy?
18
Written response
1 point
Which electrolyte should be monitored when a mineralocorticoid receptor antagonist is used for HFrEF?
19
Choose one
1 point
For which rhythm pattern is adenosine intended, according to the clinical guidance?
- A
Any irregular tachycardia
- B
A regular rhythm
- C
Only pulseless ventricular fibrillation
- D
Any rhythm, regardless of regularity
20
Choose one
1 point
In acute decompensated heart failure, when may clinicians consider noninvasive ventilation?
- A
For every patient with heart failure, regardless of clinical condition or availability
- B
When clinically appropriate and available
- C
Only after a fluid bolus has been given
- D
As a replacement for assessing airway and breathing